Generic versus brand-name cardiovascular drugs: a remarkable update.

Saved in:

Bibliographic Details
Main Authors:	Maria Elena Flacco, Giorgia Fragassi, Lamberto Manzoli
Format:	Article
Language:	English
Published:	Milano University Press 2015-12-01
Series:	Epidemiology, Biostatistics and Public Health
Online Access:	http://ebph.it/article/view/11651
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nonobstructive Versus Obstructive Coronary Artery Disease in Acute Coronary Syndrome: A Meta‐Analysis
by: Carmine Pizzi, et al.
Published: (2016-12-01)

Generics versus branded generics: A case of confusion
by: Proteesh Rana, et al.
Published: (2025-01-01)

Can Generic Medications Be a Safe and Effective Alternative to Brand-Name Drugs for Cardiovascular Disease Treatment? A Systematic Review and Meta-Analysis
by: Bing Luo, et al.
Published: (2025-03-01)

Quality of reporting of bioequivalence trials comparing generic to brand name drugs: a methodological systematic review.
by: Amélie van der Meersch, et al.
Published: (2011-01-01)

The issues of the circulation of original brand-name immunosuppressants with a narrow therapeutic window and their generics
by: N. A. Tomilina
Published: (2018-08-01)

Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
by: A. K. Singh, et al.
Published: (2011-01-01)

Comparative Analysis of the Effectiveness of Generic and Brand-Name Cefepime: A Multicenter Retrospective Cohort Study
by: Chih-Huang Li, et al.
Published: (2025-01-01)

THE PROBLEMS ASSOCIATED WITH SWITCHING BRAND-NAME ANTIEPILEPTIC DRUGS TO GENERICS: A FOCUS ON TOPAMAX: A REVIEW OF LITERATURE AND A CASE REPORT
by: K. Yu. Mukhin, et al.
Published: (2016-08-01)

The Generic Name Trombiculoides Jacot, 1938
by: G. W. Wharton
Published: (1948-01-01)

Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly<subtitle>A critical review and re-analysis of 15 meta-analyses</subtitle>
by: Lamberto Manzoli, et al.
Published: (2012-07-01)

Cervical cerclage for prevention of preterm birth and adverse perinatal outcome in twin pregnancies with short cervical length or cervical dilatation: A systematic review and meta-analysis.
by: Francesco D'Antonio, et al.
Published: (2023-08-01)

Blood phosphorylated Tau181 reliably differentiates amyloid‐positive from amyloid‐negative subjects in the Alzheimer's disease continuum: A systematic review and meta‐analysis
by: Annibale Antonioni, et al.
Published: (2025-01-01)

Breaking brand: an observational study on pharmacy-hospital-patient relationships and generic drug utilisation in Japan
by: Sayaka Nakamura, et al.
Published: (2025-05-01)

Brand Name and Generic Proton Pump Inhibitor Prescriptions in the United States: Insights from the National Ambulatory Medical Care Survey (2006–2010)
by: Andrew J. Gawron, et al.
Published: (2015-01-01)

On the Im/Propriety of Brand Names
by: William Mazzarella
Published: (2015-09-01)

The Indian Battle of Selecting a Brand versus Generic Medicine Continues: A Cost Variation Study of Oral Fluoroquinolones
by: Pallavi Dhanvijay, et al.
Published: (2025-03-01)

Comparative analysis of thrombocytopenia incidence in patients treated with generic vs. brand-name linezolid: a cohort study utilizing hospital electronic medical records
by: Zhizhou Wang, et al.
Published: (2025-06-01)

To blend so as to brand: a study of trademarks and brand names
by: Jelena Danilović Jeremić, et al.
Published: (2019-12-01)

Effect of Customer Name on Brand Choices:
by: Taku Togawa, et al.
Published: (2025-03-01)

Competing sexual-asexual generic names in Agaricomycotina (Basidiomycota) with recommendations for use
by: Joost A. Stalpers, et al.
Published: (2021-08-01)

The Generic Names Blankaartia Oudemans 1911, and Trombiculoides Jacot, 1938 (Acari: Trombiculidae)
by: H. S. Fuller, et al.
Published: (1951-01-01)

Comparative analysis of safety and efficacy between brand and generic lamotrigine products in the Saudi market
by: Haya Alotaibi, et al.
Published: (2025-07-01)

ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

MEANINGS ATTRIBUTED TO GENERIC DRUGS BY THE ELDERLY
by: Sabrina Brena de Nóbrega, et al.
Published: (2012-04-01)

MEANINGS ATTRIBUTED TO GENERIC DRUGS BY THE ELDERLY
by: Sabrina Brena de Nóbrega, et al.
Published: (2012-04-01)

MEANINGS ATTRIBUTED TO GENERIC DRUGS BY THE ELDERLY
by: Sabrina Brena de Nóbrega, et al.
Published: (2012-04-01)

Pharmacoeconomic Analysis of Treating Lung Cancer with Different Regimens Using the Cheapest and Costliest Brand and the Generic Jan Aushadhi Drugs Marketed in India
by: Abhishek Krishna, et al.
Published: (2024-04-01)

A FIT4NER Generic Approach for Framework-Independent Medical Named Entity Recognition
by: Florian Freund, et al.
Published: (2025-06-01)

Customers’ evaluations after a bank renaming: effects of brand name change on brand personality, brand attitudes and customers’ satisfaction
by: Wafa M’Sallem, et al.
Published: (2009-11-01)

Antimicrobial drug-nutrition interactions: Consistency of information for generic drugs
by: Nikolić Božana
Published: (2020-01-01)

NON-BIOLOGICAL COMPLEX DRUGS CONCEPT IN GENERIC DRUGS DEVELOPMENT
by: D. V. Goryachev, et al.
Published: (2018-03-01)

Conveying meaning in brand names by using time-inverted messages
by: Robert Schorn, et al.
Published: (2013-12-01)

Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY)
by: S. Yu. Martsevich, et al.
Published: (2020-11-01)

The problem of choice: original drug or generic? Emphasis on rosuvastatin
by: O. A. Polyakova, et al.
Published: (2022-05-01)

WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

Switching Therapy to the Second Brand of Generic Atorvastatin: A 6-Month Retrospective Cohort, Real-World Study
by: Panisa Manasirisuk, et al.
Published: (2025-05-01)

Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data
by: Solem CT, et al.
Published: (2016-10-01)

Effectiveness of tailored talks between a cancer screening specialist and general practitioners to improve the uptake of colorectal cancer screening in Ancona (Italy) during the pandemic period
by: Cecilia Acuti Martellucci, et al.
Published: (2024-12-01)

Planning and Evaluation of Bioequivalence Studies of Telmisartan Generic Drug Products
by: A. L. Khokhlov, et al.
Published: (2019-09-01)

<p><strong>A new species of <em>Amboroppia </em>(Acari, Oribatida, Oppiidae) from the Peruvian Andes, with remarks on generic diagnosis</strong></p>
by: Sergey G. Ermilov, et al.
Published: (2022-07-01)